Biomarkers and Antithrombotic Treatment in Cervical Artery Dissection - TREAT-CAD

PHASE3CompletedINTERVENTIONAL
Enrollment

194

Participants

Timeline

Start Date

September 30, 2013

Primary Completion Date

June 30, 2019

Study Completion Date

June 30, 2019

Conditions
Cervical Artery Dissection
Interventions
DRUG

Acetylsalicylic acid

Acetylsalicylic acid, 300mg o.p.d.

DRUG

Vitamin K antagonist

Vitamin K-antagonists, target INR 2.0-3.0

Trial Locations (10)

Unknown

University Hospital, Stroke Center Bispebjerg Hospital Copenhagen, Denmark, Copenhagen

University Hospital, Stroke Center Charite Berlin, Germany, Berlin

University Hospital, Stroke Center LMU Munich, Germany, Munich

Kantonsspital, Stroke Center Aarau, Switzerland, Aarau

University Hospital, Stroke Center Basel, Switzerland, Basel

University Hospital, Stroke Center Inselspital Berne, Switzerland, Bern

University Hospital, Stroke Center Geneva, Switzerland, Geneva

University Hospital, Stroke Center CHUV Lausanne, Switzerland, Lausanne

Kantonsspital, Stroke Center St. Gallen, Switzerland, Sankt Gallen

University Hospital, Stroke Center Zurich, Switzerland, Zurich

All Listed Sponsors
lead

Stefan Engelter

OTHER

NCT02046460 - Biomarkers and Antithrombotic Treatment in Cervical Artery Dissection - TREAT-CAD | Biotech Hunter | Biotech Hunter